Gene Therapy for Autoimmune Disease

This publication has 33 references indexed in Scilit:

• Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.
  Journal of Clinical Investigation, 1996
• Attenuation of collagen‐induced arthritis in mice by treatment with vector cells engineered to secrete interleukin‐13
  European Journal of Immunology, 1996
• Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
  Nature, 1996
• Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases
  Immunology Today, 1995
• Green Fluorescent Protein as a Marker for Gene Expression
  Science, 1994
• Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
  Arthritis & Rheumatism, 1993
• Report to the NIH Recombinant DNA Advisory Committee on Murine Replication-Competent Retrovirus (RCR) Assays (February 17, 1993)
  Human Gene Therapy, 1993
• Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
  The Journal of Experimental Medicine, 1992
• Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody
  Journal of Neuroimmunology, 1992
• Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein
  Published by Elsevier ,1992